NCAM1 and neoplasm: In fact, it is currently known that CD56+ T and NK cells can destroy HCC cells, although it is likely that they are unable to exert their anti-tumor activity in vivo because they are reduced in the patient’s livers and are scarce in those with metastatic disease [167,168].